Protagonist Therapeutics is a discovery through late-stage development biopharmaceutical company. Two novel peptides derived from Protagonist's proprietary discovery platform are currently in advanced ...
Takeda Pharmaceutical Company ( ($TAK) ) has provided an announcement. In November 2025, Takeda Pharmaceutical Company announced significant ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback